GlassScriptPhysician profile
Jerry S Yang
NPI 1841700523
$16,197.66
in general payments reported to CMS, 2019-2025
39 companies · $6,990 in 2025
The $6,990 reported for 2025 was more than what 99% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $524 · 2023: $4,780 · 2024: $3,904 · 2025: $6,990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Travel and Lodging: $805 · Education: $277 · Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,532.78 |
| Travel and Lodging | $804.85 |
| Education | $276.64 |
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,251.54 | 2023-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,754.29 | 2022-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Inspire Medical Systems, INC. | $1,642.54 | 2023-2025 | Inspire |
| Harmony Biosciences LLC | $1,271.93 | 2023-2025 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,060.40 | 2023-2025 | Ofev, Stiolto Respimat, Jascayd |
| United Therapeutics Corporation | $880.78 | 2023-2025 | Tyvaso, Tyvaso |
| Insmed, INC. | $583.67 | 2024-2025 | Arikayce, Brinsupri |
| Actelion Pharmaceuticals US, INC. | $547.86 | 2023-2025 | Opsumit, Uptravi, Opsynvi |
| Takeda Pharmaceuticals U.S.A., INC. | $547.13 | 2023-2025 | Glassia, Hyqvia |
| Inogen, INC. | $508.65 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Mylan Specialty L.P. | $405.10 | 2023-2024 | Yupelri, Yupelri |
| Regeneron Healthcare Solutions, INC. | $374.53 | 2023-2025 | Dupixent |
| Grifols USA, LLC | $372.01 | 2023-2025 | Prolastin-C Liquid |
| Pulmonx Corporation | $362.43 | 2023-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Merck Sharp & Dohme LLC | $351.98 | 2023-2025 | Keytruda, Winrevair |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $304.11 | 2023-2025 | |
| Electromed, INC. | $281.41 | 2023-2025 | Smartvest |
| Verona Pharma, INC. | $263.97 | 2025 | Ohtuvayre |
| Axonics, INC. | $261.08 | 2023 | Axonics |
| Paratek Pharmaceuticals, INC. | $260.69 | 2023-2025 | Nuzyra |
| Bayer Healthcare Pharmaceuticals INC. | $234.68 | 2023-2025 | |
| Abbvie INC. | $222.70 | 2022-2023 | |
| Axsome Therapeutics, INC. | $196.46 | 2023-2025 | Sunosi |
| Idorsia Pharmaceuticals US INC | $160.08 | 2024 | Quviviq |
| Lilly USA, LLC | $153.26 | 2022-2025 | Zepbound |
| Abbott Laboratories | $142.90 | 2022 | |
| Ethicon INC. | $122.05 | 2024 | Monarch Platform |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $122.00 | 2025 | Caplyta |
| Resmed Corp | $114.00 | 2023-2025 | |
| Philips North America LLC | $112.12 | 2024-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Baxter Healthcare | $69.24 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Mannkind Corporation | $59.40 | 2023 | Afrezza |
| Fisher & Paykel Healthcare INC | $41.24 | 2025 | Fisher & Paykel Healthcare |
| Avadel Cns Pharmaceuticals, LLC | $38.69 | 2025 | Lumryz |
| Caris Mpi, INC. | $34.24 | 2025 | Mi Cancer Seek |
| Mallinckrodt Hospital Products INC. | $27.47 | 2025 | Acthar |
| Tactile Systems Technology INC | $22.73 | 2023 | Entre Plus, Flexitouch Plus |
| Alkermes, INC. | $20.41 | 2022 | |
| Pfizer INC. | $17.89 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.